Investigation Report on China’s Glimepiride Market, 2018-2022

Publisher Name :
Date: 29-Nov-2018
No. of pages: 30

Glimepiride is a third-generation sulfonylurea insulin secretagogue. Sanofi’s brand-name drug (trade name: Amaryl) have been marketed in many countries after it was approved by the FDA (U.S. Food and Drug Administration) on Nov. 30, 1995. Glimepiride is the sulfonylurea hypoglycemic agent that has best clinical effectiveness as well as the first sulfonylurea approved by the FDA to be used together with insulin. It does much better in sensitizing and simulating insulin than other sulfonylureas. For type 2 diabetic patients with insulin resistance (reduced glucose utilization in peripheral tissues), Glimepiride reduces blood glucose by sensitizing and simulating insulin. For type 2 diabetic patients with insulin secretion dysfunction, Glimepiride reduces blood glucose by stimulating insulin secretion.

According to CRI, with the development of China’s economy, the rise of urbanization level, and the aging of population, the life style of Chinese people is changing, which increases the obese population and the incidence of diabetes in China. It is estimated that the number of type 2 diabetic patients in China had surpassed 1 million by the end of 2017, and is growing by 1.5 million to 2 million every year. The growing number of diabetics in China promotes the growth of the antidiabetic drug market.

According to CRI, generic products have sprung up one after another since 2004 when Sanofi (Beijing) Pharmaceutical Co., Ltd. launched Amaryl in China. In 2017, the market size of Glimepiride in China was about CNY 302 million. There are over 10 Glimepiride manufacturers in China. The major market players include Sanofi (Beijing) Pharmaceutical Co., Ltd., Jiangsu Wanbang Biopharmaceuticals Co., Ltd., CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., and Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd. By sales value, in 2017, Sanofi (Beijing) Pharmaceutical Co., Ltd.’s Amaryl captured more than 80% share of China’s Glimepiride market.

It is expected that as the number of diabetics continues to grow, China’s Glimepiride market will have huge growth potential in the next few years.

Topics Covered:


  • Situation of diabetes in China

  • Sales of Glimepiride in China

  • Competition on China’s Glimepiride market

  • Prices of Glimepiride in China

  • Forecasts on China’s Glimepiride market from 2018 to 2022

Investigation Report on China’s Glimepiride Market, 2018-2022

Table of Contents

1 Relevant Concepts of Glimepiride
1.1 Indications for Glimepiride
1.2 Development of Glimepiride in China
1.3 Governmental Approval of Glimepiride in China

2 Sales of Glimepiride in China, 2013-2017
2.1 Sales Value of Glimepiride
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Glimepiride
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Glimepiride by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Pills

3 Analysis on Major Glimepiride Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Glimepiride Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Sanofi (Beijing) Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Sanofi (Beijing) Pharmaceutical Co., Ltd.’s Glimepiride in China
3.3 Jiangsu Wanbang Biopharmaceuticals Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Jiangsu Wanbang Biopharmaceuticals Co., Ltd.’s Glimepiride in China
3.4 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
3.5 Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd.
3.6 Sanofi

4 Prices of Glimepiride in China, 2017-2018
4.1 Sanofi (Beijing) Pharmaceutical Co., Ltd. (Amaryl)
4.2 Jiangsu Wanbang Biopharmaceuticals Co., Ltd. (Wansuping)
4.3 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (Linmeixin)
4.4 Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd. (Yousu)
4.5 Sanofi (Amaryl)

5 Prospect of China’s Glimepiride Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Glimepiride in China, 2013-2017
Chart Sales Value of Glimepiride in Parts of China, 2013-2017
Chart Sales Volume of Glimepiride in China, 2013-2017
Chart Sales Volume of Glimepiride in Parts of China, 2013-2017
Chart Sales Value of Glimepiride Tablets in China, 2013-2017
Chart Sales Volume of Glimepiride Tablets in China, 2013-2017
Chart Sales Value of Glimepiride Capsules in China, 2013-2017
Chart Sales Value of Glimepiride Pills in China, 2013-2017
Chart Sales Volume of Glimepiride Pills in China, 2013-2017
Chart Market Share of Top 5 Glimepiride Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Glimepiride Manufacturers by Sales Volume in China, 2013-2017
Chart Sales Value of Sanofi (Beijing) Pharmaceutical Co., Ltd.’s Glimepiride, 2013-2017
Chart Sales Volume of Sanofi (Beijing) Pharmaceutical Co., Ltd.’s Glimepiride, 2013-2017
Chart Sales Value of Jiangsu Wanbang Biopharmaceuticals Co., Ltd.’s Glimepiride, 2013-2017
Chart Sales Value of CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.’s Glimepiride, 2013-2017
Chart Sales Value of Sanofi’s Glimepiride, 2013-2017
Chart Prices of Sanofi (Beijing) Pharmaceutical Co., Ltd.’s Glimepiride in Parts of China, 2017-2018
Chart Prices of Jiangsu Wanbang Biopharmaceuticals Co., Ltd.’s Glimepiride in Parts of China, 2017-2018
Chart Prices of CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.’s Glimepiride in Parts of China, 2017-2018
Chart Prices of Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd.’s Glimepiride in Parts of China, 2017-2018
Chart Prices of Sanofi’s Glimepiride in Parts of China, 2017-2018

  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs